Beijing Hotgen Biotech

688068

The Forward Price-to-Book (P/B) Ratio measures a company’s current share price relative to its projected book value per share for the end of the current year. This forward-looking metric provides insight into how much investors are willing to pay today for each dollar of anticipated asset value.

The Forward P/Revenue ratio measures a company’s stock price relative to its expected revenue per share for the current year. This ratio helps investors assess how much they are paying for each dollar of revenue the company is forecasted to generate.

The Forward EV/Revenue Ratio measures a company’s enterprise value (EV) relative to its projected revenue for the current year. This forward-looking metric provides insight into how much investors are willing to pay today for each dollar of expected future revenue, taking both equity and debt into account.

The EV/EBITDA ratio measures a company’s enterprise value (EV) relative to its expected earnings before interest, taxes, depreciation, and amortization (EBITDA) in latest unreported year. This ratio is widely used to evaluate a company’s overall value and operating profitability, accounting for both debt and equity.

FCF yield measures the free cash flow a company generates relative to its market capitalization. This metric helps investors evaluate how much cash flow a company is producing relative to its market value.

Operating Cash Flow Yield compares a company’s operating cash flow to its market capitalization. It shows how much real operating cash a business generates for each dollar investors have paid for the stock.

The Forward PEG Ratio refines the Forward P/E Ratio by incorporating projected earnings growth. It is calculated by dividing the Forward P/E Ratio by the expected earnings growth rate for the current unreported year. This metric provides a more comprehensive valuation assessment, factoring in both price relative to earnings and the company’s future growth potential.